Healios K.K.
4593.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥19,000 | ¥22,000 | ¥38,000 | ¥18,000 |
| % Growth | -13.6% | -42.1% | 111.1% | – |
| Cost of Goods Sold | ¥113,000 | ¥135,000 | ¥97,000 | ¥30,000 |
| Gross Profit | -¥94,000 | -¥113,000 | -¥59,000 | -¥12,000 |
| % Margin | -494.7% | -513.6% | -155.3% | -66.7% |
| R&D Expenses | ¥467,000 | ¥584,000 | ¥482,000 | ¥486,000 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥203,000 | ¥168,000 | ¥222,000 | ¥372,000 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥670,000 | ¥752,000 | ¥704,000 | ¥858,000 |
| Operating Income | -¥764,000 | -¥865,000 | -¥763,000 | -¥870,000 |
| % Margin | -4,021.1% | -3,931.8% | -2,007.9% | -4,833.3% |
| Other Income/Exp. Net | ¥1,333,000 | -¥1,260,000 | -¥1,816,000 | ¥1,313,000 |
| Pre-Tax Income | ¥569,000 | -¥2,125,000 | -¥2,579,000 | ¥443,000 |
| Tax Expense | ¥6,000 | ¥21,000 | -¥16,000 | ¥195,000 |
| Net Income | ¥563,000 | -¥2,148,000 | -¥2,561,000 | ¥256,000 |
| % Margin | 2,963.2% | -9,763.6% | -6,739.5% | 1,422.2% |
| EPS | 4.89 | -20.31 | -26.72 | 2.84 |
| % Growth | 124.1% | 24% | -1,040.8% | – |
| EPS Diluted | 4.89 | -20.31 | -26.72 | 2.84 |
| Weighted Avg Shares Out | 115,453 | 105,753 | 95,877 | 90,186 |
| Weighted Avg Shares Out Dil | 115,453 | 105,753 | 95,877 | 90,186 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥267,000 | ¥227,000 | ¥273,000 | ¥0 |
| Interest Expense | ¥0 | ¥1,521,000 | ¥2,108,000 | -¥1,368,000 |
| Depreciation & Amortization | ¥68,000 | ¥67,000 | ¥68,000 | ¥80,000 |
| EBITDA | ¥637,000 | -¥536,000 | -¥403,000 | -¥786,000 |
| % Margin | 3,352.6% | -2,436.4% | -1,060.5% | -4,366.7% |